<code id='8453E7466B'></code><style id='8453E7466B'></style>
    • <acronym id='8453E7466B'></acronym>
      <center id='8453E7466B'><center id='8453E7466B'><tfoot id='8453E7466B'></tfoot></center><abbr id='8453E7466B'><dir id='8453E7466B'><tfoot id='8453E7466B'></tfoot><noframes id='8453E7466B'>

    • <optgroup id='8453E7466B'><strike id='8453E7466B'><sup id='8453E7466B'></sup></strike><code id='8453E7466B'></code></optgroup>
        1. <b id='8453E7466B'><label id='8453E7466B'><select id='8453E7466B'><dt id='8453E7466B'><span id='8453E7466B'></span></dt></select></label></b><u id='8453E7466B'></u>
          <i id='8453E7466B'><strike id='8453E7466B'><tt id='8453E7466B'><pre id='8453E7466B'></pre></tt></strike></i>

          leisure time

          leisure time

          author:focus    Page View:6544
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          Anesthesiologist group: stop taking Ozempic before surgery
          Anesthesiologist group: stop taking Ozempic before surgery

          EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

          read more
          Kellogg’s is going to war over Mexico’s nutrition label rules
          Kellogg’s is going to war over Mexico’s nutrition label rules

          AlexHogan/STATMEXICOCITY—Kellogg’siswagingawarhereoverTigreToñoandSamelTucán.A2019policyrequirescomp

          read more
          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more

          Do more moles mean more problems? Not so, says new study

          Thenumberofmolesisnotagoodindicatorofcancer'saggressiveness.APStockDermatologistsconstantlyhammerhom